Paclitaxel trevatide Completed Phase 2 Trials for Tumors Metastatic to Brain / Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02048059ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases
NCT01480583GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases